Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 17:03
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 26°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
Ç÷´ç ÀÇÁ¸¼º Àν¶¸° ¹ÝÀÀÀ¸·Î ¾ÈÀüÇÏ°í ¾ÈÁ¤µÈ Ç÷¾ÐÁ¶Àý.
ÀÌ»óµ· ±âÀÚ
2019-08-08 14:01
[Interview]
¡°°ñ´Ù°øÁõ »çȸÀû ÀÎÁöµµ¡¤Ä¡·áÀ² ²ø¾î¿Ã¸± °Í¡±
ÀÓ¼¼Çü ±âÀÚ
2019-08-08 13:58
[Sub Story]
¸ñÇ¥Ç÷´ç °í¼ö ½ÉÇ÷°ü ÇýÅà ¾à¹° ¾àÁø
ÀÌ»óµ· ±âÀÚ
2019-08-08 13:43
[Cover Story]
³»ºÐºñ´ë»çÁúȯ »ï°¢°í¸® ºñ¸¸-Àν¶¸°ÀúÇ×¼º-ÀÌ»óÁöÁúÇ÷Áõ±îÁö
ÀÌ»óµ· ±âÀÚ
2019-08-08 13:42
[Sub Story]
4Á¦¿ä¹ý¿¡¼ ¿¥Æı۸®Ç÷ÎÁø vs ´ÙÆı۸®Ç÷ÎÁø
ÀÌ»óµ· ±âÀÚ
2019-08-08 13:38
¶óÀÎ
[Sub Story]
½ÉÇ÷°üÁúȯ º´·ÂÀÚ ÁöÁú¡¤Ç÷¾ÐÀº °ÇÏ°Ô¡é
ÀÌ»óµ· ±âÀÚ
2019-08-08 13:34
[Sub Story]
¡°½ÉºÎÀü¡¤´ç´¢º´ ȯÀÚ¿¡ SGLT-2¾ïÁ¦Á¦¡±
THE MOST
2019-08-08 13:25
[Sub Story]
Å׳׸®±Û¸³Æ¾, ¡®±º°èÀÏÇС¯ DPP-4¾ïÁ¦Á¦·Î ³ª¼³±î
ÀÓ¼¼Çü ±âÀÚ
2019-08-08 13:09
[Sub Story]
¡®LDL-C¡¯ ÁÙÀÌ´Â DPP-4¾ïÁ¦Á¦ ¾Æ³ª±Û¸³Æ¾
ÀÓ¼¼Çü ±âÀÚ
2019-08-08 13:02
[Sub Story]
¼ºÀÎ 5¸í Áß 1¸íÀÌ °ñ´Ù°øÁõ, 2¸í Áß 1¸íÀÌ °ñ°¨¼ÒÁõ
ÀÓ¼¼Çü ±âÀÚ
2019-08-08 12:53
¶óÀÎ
[Sub Story]
ȯÀÚ ¸ÂÃãÇü ÃֽŠ°ñ´Ù°øÁõ Ä¡·áÀü·« Á¤¸®
ÀÓ¼¼Çü ±âÀÚ
2019-08-08 12:49
[Sub Story]
°ñ¹Ðµµ + °ñ°¨¼ÒÁõ ÇÔ²² °í·ÁÇØ Áø´Ü¡¤Ä¡·á ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2019-08-08 12:44
[Sub Story]
´ç´¢º´ ȯÀÚ LDLÄÝ·¹½ºÅ×·Ñ Á¶Àý °ÇÏ°Ô
ÀÌ»óµ· ±âÀÚ
2019-07-31 17:17
[Sub Story]
¿À¸Þ°¡-3Áö¹æ»ê ¿ªÇÒ ÀçÆò°¡
ÀÌ»óµ· ±âÀÚ
2019-07-31 17:09
[Sub Story]
ºñ¸¸¡¤Àν¶¸°ÀúÇ×¼ºÀÌ ÀÌ»óÁöÁúÇ÷Áõ ¿øÀÎ
ÀÌ»óµ· ±âÀÚ
2019-07-31 17:06
¶óÀÎ
[Interview]
¡°´ç´¢º´ ȯÀÚ ÁöÁúÄ¡·á LDL¡¤TG¡¤HDL ¸ðµÎ °ø·«Çؾߡ±
ÀÌ»óµ· ±âÀÚ
2019-07-31 17:04
[Deep in Guideline]
ȯÀÚ Á¢±Ù¼ººÎÅÍ°¡ ºñ¸¸Ä¡·áÀÇ ½ÃÀÛ
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 17:00
[Conference Report]
Á¦¹Ì±Û¸³Æ¾ Ç÷´çº¯µ¿¼º °³¼± ¿¬Å¸¼® ¾ÈŸ
ÀÌ»óµ· ±âÀÚ
2019-07-31 16:54
[Interview]
DPP-4¾ïÁ¦Á¦ Ç÷´çº¯µ¿¼º¿¡ Æ¯È ÀÔÁõ
ÀÌ»óµ· ±âÀÚ
2019-07-31 16:03
[Conference Report]
À¯ÀüÀû Ãë¾à¼º, LDL-C °ÇÏÈ¿°ú ¿¹ÃøÀÎÀÚ µÇ³ª
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 15:35
-
1
2
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top